UK Markets open in 1 hr 27 mins

BRIEF-Eagle Pharmaceuticals Commences Pivotal Study For Fulvestrant (AZN)

Dec 7 (Reuters) - Eagle Pharmaceuticals Inc:

* EAGLE PHARMACEUTICALS COMMENCES PIVOTAL STUDY FOR FULVESTRANT

* EAGLE PHARMACEUTICALS- ANTICIPATES COMPLETION OF FULVESTRANT STUDY WITHIN TWELVE MONTHS, AND AN EXPECTED NDA FILING IN Q4 OF 2018 Source text for Eikon: Further company coverage:

See Also: